Drug Discovery World

OCTOBER 5, 2022

For example, to aid researchers and clinicians, we have developed tools such as the droplet tool to dispense cells or the digi triaxial version which can print up to three different cell incorporated biomaterials with different manipulations according to the tissue. This precision printing in 3D requires automation to make it accurate enough.

Drugs 52

Drugs Regulation Manufacturing Medicine 52

Roots Analysis

MARCH 8, 2023

Over time, various research studies have demonstrated the potential of exosomes ( membrane bound extracellular vesicles) in disease diagnosis, drug delivery and therapeutic applications. In addition, they are involved in regulating the expression of the targets that are linked to RNA as they can affect the expression of RNA.

RNA 52

RNA Drug Delivery DNA Development 52

Pharmaceutical Technology

OCTOBER 26, 2022

Data indicates that the global nanopharmaceutical drugs market size reached USD 53.85 According to GlobalData’s Nanopharmaceuticals Thematic Research report, the vast majority of marketed and pipeline nanopharmaceuticals are being used to treat a wide range of cancer indications, highlighting the ongoing unmet needs in this area.

Manufacturing 130

Manufacturing Drug Delivery Systems Contamination Drug Delivery 130

The Pharma Data

NOVEMBER 2, 2020

Research agreement to investigate the feasibility of a proprietary biotechnology process for the industrial production of psilocybin API. “Psychedelic agents are a promising new class of therapeutic drug. from 2017 to 2023 according to Allied Market Research. .” About XPhyto Therapeutics Corp.

Production 52

Production Development Drug Delivery Drugs 52

Drug Discovery World

OCTOBER 18, 2023

Sara Donnelly, Director of Research Planning and Business Development at PhoenixBio USA explores why the right pre-clinical model is essential for teams wanting to advance adeno-associated virus vector-based gene therapies. Adeno-associated virus (AAV) vector-based gene therapies hold exceptional promise across a range of disease areas.

Gene Therapy 64

Gene Therapy Gene Clinical Trials Clinical Trials 64

The Pharma Data

DECEMBER 20, 2020

With this acquisition we are expanding our product pipeline to include psychedelic therapeutics, incorporating elements of our IP around drug delivery technology in which we already have prototypes developed, which we believe will propel us towards clinical studies relatively quickly. Ahmad Doroudian, CEO of BetterLife.

Drug Delivery 52

Drug Delivery Containment Production Development 52

The Pharma Data

JANUARY 27, 2021

” Vektor is a German narcotics manufacturer, developer, and researcher located in the district of Biberach, Baden-Württemberg, Germany. In 2020, XPhyto confirmed successful activation of its peptide-based biosensor program when delivered using Vektor’s sublingual drug delivery platform.

Drugs 52

Drugs Manufacturing Drug Delivery Production 52

Roots Analysis

OCTOBER 5, 2023

Driven by the increasing need for safe and efficient medical devices and drug delivery systems, the pharmaceutical polymers / medical grade polymers domain is advancing significantly. Vaccine Adjuvants: Polymers often serve as carriers for releasing the antigen and thereby regulating the immunological responses.

Manufacturing 40

Manufacturing Drug Delivery Systems Drug Delivery Packaging 40

The Pharma Data

APRIL 27, 2021

A Minipump Continuous Drug Infusion Dog Model System to Identify Candidate Drugs and Drug Delivery Rates for Intracameral IOP-lowering Implants. A Retrospective Analysis: Visual Field Progression and Visual Acuity following Administration of Brimonidine Drug Delivery System. NORTH CHICAGO, Ill.

Research 40

Research Drug Delivery Systems Drug Delivery Production 40

Camargo

OCTOBER 14, 2020

The establishment of the DHCoE is the latest of many signs that the FDA is working closely with other stakeholders to make sure that regulations keep pace with the rapid advancements in this space. Approval of the Month: FDA Approves First Closed-Loop Monitoring and Drug Delivery Device.

Development 196

Development Insulin Drug Delivery Production 196

The Pharma Data

DECEMBER 14, 2020

Attaining the goals of any given psychedelic-based endeavour will require the removal of federally scheduled enforcement status and global United Nations drug conventions of which the United States and Canada are both participants. About BetterLife Pharma Inc. BetterLife Pharma Inc. About Transcend Biodynamics.

Drug Delivery 40

Drug Delivery Containment Manufacturing Drugs 40

pharmaphorum

JUNE 10, 2021

The need for firms to make a reasonable profit is paramount in today’s world; healthy pharmaceutical research and manufacturing are the keys to ending disease, curing chronic conditions, and discovering new therapies and vaccines that address the latest medical challenges.

Manufacturing 104

Manufacturing Pharma Companies Drugs Pharmacy 104

The Pharma Data

NOVEMBER 9, 2020

Dr. Löbenberg holds Health Canada licences for research and analytical testing of a wide range of psychedelic compounds under the Controlled Drugs and Substance Act and research and analytical testing licences for cannabis under the Cannabis Act. DMT (N,N-dimethyltryptamine). Prof. XPhyto Therapeutics Corp.

Development 40

Development Drugs Drug Delivery Production 40

The Pharma Data

JANUARY 25, 2021

The Company continues to enjoy freedom to use panobinostat for research purposes and believes the relevant Secura Bio patents may marginally delay a launch of MTX110 for DIPG but not MTX110 for GBM. ” This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014 (MAR).

Containment 52

Containment Drug Delivery Licensing Licensing 52

XTalks

JUNE 15, 2022

The featured speakers will discuss how life science manufacturers can now save time, money and resources and increase time to market by doing away with fully customized QMS solutions — while remaining compliant with industry regulations and standards. Royal Philips has been researching and developing treatment for critical limb ischemia.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

Roots Analysis

OCTOBER 22, 2023

In the last few years, researchers have become interested in using in vitro transcribed (IVT) mRNA as a drug delivery agent. Some of the key concerns associated with RNA therapeutics are as below: Delivery-related Concerns: RNA-based molecules are unstable due to their large molecular size and negative charge.

RNA 40

RNA Protein Genetics Gene Expression 40

The Pharma Data

JANUARY 27, 2021

Utilizing drug delivery platform technologies, BetterLife is refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus.

In-Vitro 52

In-Vitro Containment Drugs Production 52

Delveinsight

FEBRUARY 14, 2021

Developing a new drug requires years of research, time, and money; and in cases where winds are against the market forces and profit margins appear shallow, conducting and bearing the cost for such trials can prove to be a pretty penny. Therefore, rare disease patients were ‘orphaned’ by them and left without treatment.

Marketing 52

Marketing Clinical Trials Clinical Trials Trials 52

The Pharma Data

JANUARY 17, 2021

XPhyto has entered into two psychedelic agreements: first, for the development of industrial scale biotechnology processes for the production of psilocybin, and second, for research and development related to multiple psychedelic compounds, including psilocybin, mescaline, LSD, MDMA, DMT, among others. About XPhyto Therapeutics Corp.

Production 40

Production Drug Delivery Development Drugs 40

The Pharma Data

OCTOBER 27, 2020

is a research and development company that develops topical and transdermal consumer products including DermSafe, all made with patented Invisicare® skin delivery technology. The technology enhances the delivery of ingredients to and through the skin and is protected by patents in eleven countries. About Ovation Science Inc.

Sales 52

Sales Production Drug Delivery Development 52

Delveinsight

JANUARY 22, 2021

TAK-755 (BAX930/SHP655) is a human recombinant ADAMTS13, the plasma metalloprotease that regulates the von Willebrand Factor (VWF) multimers. To sum it all, upcoming pipeline therapies in the Thrombocytopenia drugs market are based on novel mechanisms of action that aims to target several different Thrombocytopenia patient groups.

Marketing 65

Marketing Drugs Antibody Compliance 65

The Pharma Data

JANUARY 15, 2021

Today’s milestone is an important step for patients diagnosed with this rare disease,” said Isabelle Lousada, Founder and CEO, Amyloidosis Research Consortium. Global Medical Head/Clinical Leader, Hematology & Oncology, Janssen Research & Development, LLC. The most common adverse reactions (? Learn more at www.janssen.com.

FDA Approval 52

FDA Approval Production Research Doctors 52

Delveinsight

SEPTEMBER 2, 2021

On August 18, 2021, Abiomed received breakthrough device designation from the United States Food and Drug Administration (FDA) for its Impella ECP expandable percutaneous heart pump , the world’s smallest heart pump and the first to be compatible with small-bore access and closure techniques.

Marketing 72

Marketing Radiology Drugs Drug Delivery 72

XTalks

OCTOBER 1, 2020

WeiQi Lin, MD, PhD, executive vice president of research & development and principal scientist, DURECT Corporation. Lin has made several transitions throughout her career, from being a clinician at an academic center, to academic research, to heading business development in industry. Motivations for Transition.

Scientist 52

Scientist In-Vitro Research Life Science 52